Translate
Nkgen Biotech Inc.
About
0.06USD+0.00 +0.00%
Closed • Updated at 02:09 GMT+00:00Market Cap$7.84M
Volume50.5K
Beta-11.19
RSI46.34
Nkgen Biotech Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 9 2026
NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
Mar 23 2026
NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™
Jan 22 2026
NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board
Dec 3 2025
NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.
Oct 9 2025
NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market
Recent Videos
NKGen Biotech's Debt: Growth Signal or Risky Gamble Analysis
Feb 27, 2026
My take on NK Gen Biotech's recent loan filing
Jan 19, 2026
The BioHub - The Avetix Podcast - S2 Ep75 - Paul Song- CEO of NKGen
Oct 07, 2025
NKGen Biotech's Leadership Switcheroo: My Take
Oct 03, 2025
Community Chat
Ask AI
Try asking